Tentative result for EQAI 2009

Tentative result for EQAI 2009

TENTATIVE DESIGNATED RESPONSE FOR SYPHILIS SEROLOGY PROGRAM

TRIAL 01-09-1

Control material NO.	01-09-1-1	01-09-1-2	01-09-1-3	01-09-1-4
Non treponemal test	Non Reactive	Reactive1:4	Non Reactive	Non Reactive
Treponemal test	Non Reactive	Reactive	Non Reactive	Non Reactive

TRIAL 01-09-2

Control material NO.	01-09-2-1	01-09-2-2	01-09-2-3	01-09-2-4
Non treponemal test	Reactive	Non Reactive	Non Reactive	Non Reactive
Treponemal test	Reactive	Non Reactive	Non Reactive	Non Reactive

TRIAL 01-09-3

Control material NO.	01-09-3-1	01-09-3-2	01-09-3-3	01-09-3-4
Non treponemal test	Non Reactive	Non Reactive	Reactive	Non Reactive
Treponemal test	Non Reactive	Non Reactive	Reactive	Non Reactive

TRIAL 01-09-4

Control material NO.	01-09-4-1	01-09-4-2	01-09-4-3	01-09-4-4
Non treponemal test	NS	Non Reactive	Non Reactive	Non Reactive
Treponemal test	Reactive	Non Reactive	Non Reactive	Non Reactive

TENTATIVE DESIGNATED RESPONSE FOR HEPATITIS B VIRUS SEROLOGY PROGRAM

TRIAL 02-09-1

Control material NO.	02-09-1-1	02-09-1-2	02-09-1-3	02-09-1-4
HBsAg	POSITIVE 250.9± 76.1 s/n (MEIA)	NEGATIVE 1.1± 0.3 s/n (MEIA)	NS 4.1± 1.5 s/n (MEIA)	NS 7.35±5.68 s/n (MEIA)
antiHBs	NEGATIVE 0.6±0.8 mIU/ml	NEGATIVE 1.2±0.7 mIU/ml	POSITIVE 712.7±144.4 mIU/ml	POSITIVE 606.36±234.48 mIU/ml
antiHBc	POSITIVE	POSITIVE	POSITIVE	POSITIVE
HBeAg	NEGATIVE	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	POSITIVE	NEGATIVE	POSITIVE	POSITIVE

Note : 02-09-1-3 and 02-09-1-4 came from the same sample.

TRIAL 02-09-2

Control material NO.	02-09-2-1	02-09-2-2	02-09-2-3	02-09-2-4
HBsAg	POSITIVE 313.29±33.73 s/n (MEIA)	NEGATIVE 1.60±0.56 s/n (MEIA)	NEGATIVE 1.57±0.19 s/n (MEIA)	NEGATIVE 1.39±0.11 s/n (MEIA)
antiHBs	NEGATIVE 0.44±0.58 mIU/ml	POSITIVE 61.19±16.62 mIU/ml	NEGATIVE 0.45±0.59 mIU/ml	NEGATIVE 0.42±0.57 mIU/ml
antiHBc	NS	POSITIVE	NEGATIVE	POSITIVE
HBeAg	NS	NEGATIVE	NEGATIVE	NEGATIVE
antiHBe	NEGATIVE	NS	NEGATIVE	POSITIVE

TRIAL 02-09-3
Control material NO.
02-09-3-1
02-09-3-2
02-09-3-3
02-09-3-4
HBsAg
NEGATIVE
0.52±0.16COI
(E-CLIA)
NEGATIVE
0.65±0.14 COI
(E-CLIA)
NEGATIVE
0.5±0.2COI
(E-CLIA)
NS 34.1±4.8 COI
(E-CLIA)
antiHBs
POSITIVE 47.9±23.8
mIU/ml*
POSITIVE 658.8±231.6
mIU/ml*
NEGATIVE
0.6±0.8
mIU/ml*
NEGATIVE 0.5±0.9
mIU/ml*
antiHBc
POSITIVE
NEGATIVE
NEGATIVE
NEGATIVE
HBeAg
NEGATIVE
NEGATIVE
NEGATIVE
NEGATIVE
antiHBe
NS
NEGATIVE
NEGATIVE
NEGATIVE
* All methods

TRIAL 02-09-4
Control material NO.
02-09-4-1
02-09-4-2
02-09-4-3
02-09-4-4
HBsAg
NEGATIVE
0.73±0.6
(E-CLIA)
POSITIVE
8705.58±602.21
(E-CLIA)
NEGATIVE
0.87±1.2
(E-CLIA)
NEGATIVE
0.5±0.2
(E-CLIA)
antiHBs
NEGATIVE 4.18±3.16
mIU/ml
NEGATIVE 2.02±9.76
mIU/ml
NEGATIVE
0.68±0.92
mIU/ml
POSITIVE 775.78±335.06 mIU/ml
antiHBc
POSITIVE
POSITIVE
NEGATIVE
NS
HBeAg
NEGATIVE
NEGATIVE
NEGATIVE
NEGATIVE
antiHBe
POSITIVE
POSITIVE
NEGATIVE
POSITIVE